MAMDC4
protein-codingMAM domain containing 4
Gene summary
Predicted to enable protein histidine phosphatase activity. Predicted to be involved in nervous system development. Predicted to act upstream of or within Wnt signaling pathway and protein localization to nucleus. Predicted to be located in cytosol. Predicted to be part of Wnt signalosome. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0005090
Submitter: Labcorp Genetics (formerly Invitae)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MAMDC4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_206920.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 5 | 9 | |||
| missense | 251 | 16 | 267 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 262 | 21 | 0 | 283 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_996803.2 | 27 | MANE Select | |
| Ensembl | ENSP00000319388.2 | 27 | MANE Select | |
| Ensembl | ENSP00000411339.1 | 29 | Standard | |
| Ensembl | ENSP00000411339.1 | 29 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein transport
Cellular Component
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000317446
- Coding exons
- 27
- Length
- 9855
- Individuals with no LoFs
- 122153
- Homozygous LoFs
- 24
- Heterozygous LoFs
- 3421
- Defined
- 125598
- p
- 0.0138
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.841 | 756 | 694 | 1.09 | 0.0000444 | 7177 |
| Missense (PolyPhen) | 307 | 270.33 | 1.1356 | 3078 | ||
| Synonymous | -3.02 | 375 | 308 | 1.22 | 0.0000209 | 2407 |
| Loss of Function | -0.710 | 74 | 67.7 | 1.09 | 0.00000363 | 642 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.013 | 0.013 | notable |
| Latino/Admixed American | 0.0073 | 0.0072 | notable |
| Ashkenazi Jewish | 0.0061 | 0.0061 | notable |
| East Asian | 0.0020 | 0.0019 | notable |
| Finnish | 0.024 | 0.024 | notable |
| European (Non-Finnish) | 0.019 | 0.019 | notable |
| South Asian | 0.0056 | 0.0055 | notable |
| Other | 0.016 | 0.016 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probably involved in the sorting and selective transport of receptors and ligands across polarized epithelia. {ECO:0000250|UniProtKB:Q63191}.;
Recessive Scores
- pRec
- 0.100
Intolerance Scores
- LoFtool
- 0.979
- RVIS EVS
- 1.89
- RVIS percentile EVS
- 97.28
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.146
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |